AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRISTEL PLC

Director's Dealing Mar 3, 2020

7990_dirs_2020-03-03_47c8b80c-c0ac-4ec2-aeba-adfea3042245.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8483E

Tristel PLC

03 March 2020

Tristel plc

("Tristel" or the "Company")

Director/PDMR Shareholding and Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by Liz Dixon, Finance Director, it has issued and allotted 157,523 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 March 2020. 

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the above exercise of options, the Company's issued share capital consists of 45,079,346 Ordinary Shares. Accordingly, the figure of 45,079,346 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Liz Dixon subsequently sold 157,523 Ordinary Shares at a price of 431 pence per Ordinary Share on 2 March 2020. Liz Dixon's resultant shareholding in the Company remains unchanged at 45,000 Ordinary Shares.  Liz Dixon also holds 464,865 options over Ordinary Shares which together with her shareholding represents 1.12% of the issued share capital of the Company.  Of the options held 266,667 have yet to vest.

For further information please contact:       

Tristel plc Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07854 391 303
finnCap Tel: 020 7220 0500
Geoff Nash (Corporate Finance)
Giles Rolls (Corporate Finance)
Alice Lane (ECM)

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Liz Dixon

2.               

Reason for the Notification.         Sale of Ordinary Shares

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of options over Ordinary Shares

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price Volume(s)
1p 157,523
Price(s) Volume(s)
4.31 GBP 157,523

d)

Aggregated information:

·      Aggregated volume

·      Price

Exercise of options over 157,523 Ordinary Shares at an exercise price of 1p

Sale of 157,523 Ordinary Shares at £4.31 per ordinary share

e)

Date of the transaction

02/03/2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHUPUPPWUPUGUW

Talk to a Data Expert

Have a question? We'll get back to you promptly.